Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

News Release

RSS RSS Feeds
Printer Friendly Version View printer-friendly version
<< Back
Meridian Bioscience to Present at Friedman Billings Ramsey 10th Annual Investor Conference

CINCINNATI--(BUSINESS WIRE)--Nov. 25, 2003--Meridian Bioscience, Inc. (Nasdaq:VIVO) today announced that Bill Motto, Chairman and Chief Executive Officer; Jack Kraeutler, President and Chief Operating Officer; and Rick Eberly, Executive Vice President and General Manager, Meridian Life Science, have been invited to present at the Friedman Billings Ramsey 10th Annual Investor Conference on Tuesday, December 2, 2003 at 9:30 a.m. ET at the Sheraton New York Hotel & Towers in New York City. A question and answer session will follow and some of the information provided during the session may not have been previously disclosed. Messrs. Motto, Kraeutler and Eberly will be available to meet with investors following the presentation. Requests for interviews prior to the conference should be made through Brenda Hughes, Executive Assistant, at Meridian Bioscience, telephone (513) 272-5228.

The presentation will be webcast live, and Meridian invites investors to listen to management's remarks, over the internet, on the Company's website at www.meridianbioscience.com. The archived broadcast will be available for 60 days.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. All Meridian products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers and physician offices in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.

CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700

SOURCE: Meridian Bioscience, Inc.